Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01265797 · ClinicalTrials.gov registry record · NA
Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches
A NA study, sponsored by University of Toledo Health Science Campus.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01265797 is a NA study that has completed, run by University of Toledo Health Science Campus. The registered enrollment target is 68 participants.
The verdict
NCT01265797, a NA study, has completed, sponsored by University of Toledo Health Science Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
Cranial electrotherapy stimulation (CES) may be a safe adjunct to medical treatment for pain relief in migraine patients. However, despite the number of CES studies done, many have been open label, single blinded, or have utilized a small group of patients.
Interventions
- DEVICE Sham Device
- DEVICE Cranial Electrostimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01265797
The ClinicalTrials.gov registry entry for NCT01265797 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Toledo Health Science Campus, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Device is the first listed.
NCT01265797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01265797 about?
NCT01265797 is a clinical study titled "Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches". Cranial electrotherapy stimulation (CES) may be a safe adjunct to medical treatment for pain relief in migraine patients. However, despite the number of CES studies done, many have been open label, single blinded, or have utilized a small group of patients.
What is the current status of trial NCT01265797?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2011-12. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01265797?
The interventions under investigation include: Sham Device (DEVICE), Cranial Electrostimulator (DEVICE).
Who is sponsoring clinical trial NCT01265797?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.